HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Baris Boyraz Selected Research
Baris Boyraz Research Topics
Disease
5
Neoplasms (Cancer)
01/2022 - 04/2013
3
Breast Neoplasms (Breast Cancer)
01/2022 - 04/2013
2
Leiomyoma (Uterine Fibroids)
06/2022 - 03/2022
1
Leiomyomatosis
03/2022
1
COVID-19
01/2022
1
Persistent Infection
01/2022
1
Endometrial Stromal Sarcoma
01/2022
1
Glomus Tumor (Glomus Tumors)
01/2022
1
Leiomyosarcoma
01/2022
1
Carcinoma (Carcinomatosis)
09/2021
1
Myocarditis (Carditis)
01/2021
1
Dyskeratosis Congenita (X-Linked Dyskeratosis Congenita)
12/2015
1
Idiopathic Pulmonary Fibrosis
12/2015
Drug/Important Bio-Agent (IBA)
2
Fumarate Hydratase (Fumarase)
IBA
06/2022 - 03/2022
2
Proteins (Proteins, Gene)
FDA Link
01/2022 - 01/2022
2
Immunoconjugates (Immunoconjugate)
IBA
01/2022 - 04/2013
1
S100 Proteins (S 100 Protein)
IBA
01/2022
1
Estrogen Receptors
IBA
01/2022
1
Cyclin D1
IBA
01/2022
1
Desmin
IBA
01/2022
1
Thyroglobulin
FDA Link
09/2021
1
Interleukin-6 (Interleukin 6)
IBA
01/2021
1
Glucocorticoids
IBA
01/2021
1
poly(A)-specific ribonuclease
IBA
12/2015
1
telomerase RNA (bTR)
IBA
12/2015
1
Pharmaceutical Preparations
IBA
04/2013
1
Cytotoxins (Cytolysins)
IBA
04/2013
1
Ado-Trastuzumab Emtansine
IBA
04/2013
1
Lapatinib (GW572016)
FDA Link
04/2013
1
taxane
IBA
04/2013
1
Trastuzumab (Herceptin)
FDA Link
04/2013
1
ErbB Receptors (EGF Receptor)
IBA
04/2013
1
Sulfides (Thioethers)
IBA
04/2013
1
Maytansine (Maitansine)
IBA
04/2013
Therapy/Procedure
3
Therapeutics
01/2022 - 04/2013
1
Uterine Myomectomy
03/2022
1
Drug Therapy (Chemotherapy)
04/2013